Brand Intelligence Graph
Company Overview
About Mantis Biotech
Mantis Biotech is a YC-backed AI company that builds digital twins of human physiology to synthesize diverse, realistic clinical trial populations. The company addresses one of drug development's most persistent problems: clinical trials consistently underrepresent women, elderly patients, and minorities, producing efficacy data that fails to predict real-world outcomes across populations. Mantis's AI platform generates synthetic patient data that fills these representation gaps.
Business Model & Competitive Advantage
The company emerged from stealth with a $48 million Series A in February 2026 co-led by Andreessen Horowitz's Bio fund and GV (Google Ventures), with a founding team led by CEO Georgia Witchel. The raise validates the thesis that AI-generated synthetic data can unlock clinical development stages that real-world data constraints currently block — including rare disease programs where patient populations are too small for statistically valid trials.
Competitive Landscape 2025–2026
Mantis targets the $2.6 billion average per-drug development cost, a figure dominated by late-stage trial failures that synthetic data simulation could predict earlier. As regulatory agencies warm to synthetic data for trial enrichment, Mantis is positioned at the intersection of AI, computational biology, and FDA regulatory strategy — a technically defensible and commercially timely position.
Key Differentiators
Emerging Innovator
Mantis Biotech is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare Mantis Biotech with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Mantis Biotech? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Mantis Biotech Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Mantis Biotech vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →